- Investing Ideas
- /
- Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20
Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20
Results
4
0 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
4 companies
Shanghai Pharmaceuticals Holding
Market Cap: CN¥60.4b
Shanghai Pharmaceuticals Holding Co., Ltd.
601607
CN¥17.95
7D
0.7%
1Y
-15.1%
Jointown Pharmaceutical Group
Market Cap: CN¥24.2b
Provides pharmaceutical supply chain services in China.
600998
CN¥4.85
7D
-0.8%
1Y
-15.5%
Tibet Rhodiola Pharmaceutical Holding
Market Cap: CN¥15.1b
Tibet Rhodiola Pharmaceutical Holding Co.
600211
CN¥46.70
7D
1.0%
1Y
15.3%
Hangzhou Alltest Biotech
Market Cap: CN¥5.4b
Engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally.
688606
CN¥68.95
7D
2.5%
1Y
3.3%